Cellaputics Bio - Crunchbase Company Profile & Funding

Q: Who invested in Cellaputics Bio?

Cellaputics Bio has 7 investors including Medytox Venture Investment And Dayli Partners.

Q: When was the last funding round for Cellaputics Bio?

Cellaputics Bio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Cellaputics Bio raised to date?

Cellaputics Bio has raised obfuscated.

Overview

Cellaputics Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cellaputics Bio

CB Rank

153776

Cellaputics Bio is a biotechnology company that develops cell therapy for treating degenerative and intractable diseases.

Founded

obfuscation

Private

Series A

Seongnam, Kyonggi-do, South Korea

11-50

www.cellapeuticsbio.com

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Pre-Seed

OBF

obfuscation

Key People

Kyung-Kyu Kim: Founder & CEO

Details

Legal Name

Cellaputics Bio Co., Ltd.

Also Known As

셀라퓨틱스바이오

Operating Status

Active

Company Type

For Profit

Founders

Kyung-Kyu Kim

Phone Number

+82 0 318 064 1800

Contact Email

admin@cellapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CELLA CON® Platform

A cell reprogramming technology that converts patient somatic cells into therapeutic differentiated cells using a small molecule drug formula.

CPB101

A cell therapy product derived from somatic cells reprogrammed into neuroregenerative glial cells for treating degenerative diseases.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Cellaputics Bio	3	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Medytox Venture Investment	—	Series A - Cellaputics Bio	—
Medytox Venture Investment	—	Series A - Cellaputics Bio	—
Medytox Venture Investment	—	Series A - Cellaputics Bio	—
Medytox Venture Investment	—	Series A - Cellaputics Bio	—
Medytox Venture Investment	—	Series A - Cellaputics Bio	—